Patrick Frost, PhD

Patrick Frost, PhD

Feb 02, 2016

Group 6 Copy 28
0
    Please wait...

    About This Project

    BBRI and Los Angeles VA Medical Center

    Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Geissorhiza: an evolutionary case study in the Cape Floristic Region

    The Cape Floristic Region (CFR) in South Africa is one of the most plant biodiverse places on earth with over...

    Written in Bone: was the fossil Allodesmus a seal or sea lion?

    Is the fossil Allodesmus a seal or sea lion? Allodesmus lived in the Miocene period, about 10 million years...

    Backer Badge Funded